Hadasit Bio Stock Current Valuation
| HDST Stock | 53.00 3.80 6.69% |
Valuation analysis of Hadasit Bio helps investors to measure Hadasit Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Hadasit Bio's price fluctuation is not too volatile at this time. Calculation of the real value of Hadasit Bio is based on 3 months time horizon. Increasing Hadasit Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Hadasit Bio is useful when determining the fair value of the Hadasit stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Hadasit Bio. Since Hadasit Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hadasit Stock. However, Hadasit Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 53.0 | Real 50.65 | Hype 53.0 |
The real value of Hadasit Stock, also known as its intrinsic value, is the underlying worth of Hadasit Bio Company, which is reflected in its stock price. It is based on Hadasit Bio's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Hadasit Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Hadasit Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Hadasit Bio helps investors to forecast how Hadasit stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hadasit Bio more accurately as focusing exclusively on Hadasit Bio's fundamentals will not take into account other important factors: Hadasit Bio Company Current Valuation Analysis
Hadasit Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Hadasit Bio Current Valuation | (3.4 M) |
Most of Hadasit Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hadasit Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Hadasit Bio has a Current Valuation of (3.4 Million). This is 100.02% lower than that of the Biotechnology sector and 100.07% lower than that of the Health Care industry. The current valuation for all Israel stocks is 100.02% higher than that of the company.
Hadasit Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hadasit Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hadasit Bio could also be used in its relative valuation, which is a method of valuing Hadasit Bio by comparing valuation metrics of similar companies.Hadasit Bio is currently under evaluation in current valuation category among related companies.
Hadasit Fundamentals
| Return On Equity | -0.44 | |||
| Return On Asset | -0.0296 | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | (3.4 M) | |||
| Shares Outstanding | 11.09 M | |||
| Shares Owned By Insiders | 74.99 % | |||
| Price To Book | 0.52 X | |||
| Price To Sales | 0.90 X | |||
| Gross Profit | 35.09 M | |||
| EBITDA | 28.67 M | |||
| Net Income | 28.36 M | |||
| Cash And Equivalents | 18.14 M | |||
| Cash Per Share | 1.64 X | |||
| Debt To Equity | 0.40 % | |||
| Current Ratio | 17.76 X | |||
| Book Value Per Share | 3.59 X | |||
| Cash Flow From Operations | (2.1 M) | |||
| Earnings Per Share | 2.46 X | |||
| Beta | 0.58 | |||
| Market Capitalization | 16.9 M | |||
| Total Asset | 66.41 M | |||
| Retained Earnings | (125 M) | |||
| Working Capital | 59 M | |||
| Current Asset | 61 M | |||
| Current Liabilities | 2 M | |||
| Z Score | -1.4 | |||
| Annual Yield | 0.18 % | |||
| Net Asset | 66.41 M |
About Hadasit Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hadasit Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hadasit Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hadasit Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hadasit Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hadasit Bio's short interest history, or implied volatility extrapolated from Hadasit Bio options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hadasit Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Hadasit Stock analysis
When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |